203.855.3535
MENU

We're Happy to Welcome You Back!
Here's What Our Practice is Doing to Keep You Safe at Your Next In-Office Appointment.

Learn More

Obstetrics Gynecology Conditions & Treatments - row of books

Menopausal Patients

At Dr. Garofalo’s OBGYN practice, we know that a postmenopausal woman may have issues that differ from a reproductive aged patient. We take the time to fully address our patients’ concerns and focus on evidence based strategies to provide the most effective treatments. 

Menopausal women frequently experience:

  • Vasomotor symptoms
  • Vaginal dryness
  • Urinary incontinence
  • Osteoporosis

Hot Flashes

After the Women’s Health Initiative study was terminated secondary to concerns over the safety of hormone replacement therapy (HRT), many women vowed to suffer in silence with their hot flashes. Suffer no more!

Current data reveals minimal risk of HRT use, when used in low-risk patients. At Garofalo’s OBGYN practice, we will work with our patients to find the proper medications, usually a combination of low dose estrogen and progesterone, to combat disruptive vasomotor symptoms. In accordance with the North American Menopause Society, The Food and Drug Administration and the American College of Obstetrics and Gynecology we do not recommend the use of bioidentical hormone therapy secondary to the lack of data regarding their safety and efficacy.

ACOG: Patient Resources

ACOG: Compounded Bioidentical Menopausal Hormone Therapy 

NAMS: Bioidentical Hormone Therapy

Vaginal Dryness

After menopause, the vaginal mucosa becomes thinner, drier, less elastic and more fragile secondary to the lack of estrogen. These changes may lead to vaginal and urinary tract infections as well as painful intercourse. While over the counter lubrication may provide some relief, studies have shown that vaginal estrogen is highly effective in the reduction of painful intercourse as well as postmenopausal vaginal and urinary tract infections.  

A new perspective analysis for the NHS indicates that despite its “black box” warning, low-dose vaginal estrogen does not pose an increased risk of cardiovascular disease or cancer. 

Urinary Incontinence

Many women have complaints of urinary incontinence, but few feel comfortable bringing up this concern to their health care providers. At Dr. Garofalo’s OBGYN, we take the time to question our patients about their bladder control and offer many treatment strategies for incontinence.  Read more about urinary incontinence here. 

Osteoporosis

Decreasing estrogen levels during menopause can diminish bone density, ultimately increasing the risk of osteoporosis. We review current recommendations for supplementation as well as make referrals for bone density evaluations when appropriate for all of our postmenopausal patients. 

Appointments for Telehealth:

Currently, we are happy to see patients via Telehealth for the following:

We are currently using the application Spruce to perform our Telehealth visits. Upon scheduling your appointment with our office you will receive and an invitation to download the application.  Spruce is compatible with both iPhone and Android technology.  

Schedule a Consultation